Benzodiazepine APIs Market Benefits from Rising Demand for Short-Term Anxiety Treatments
The global benzodiazepine APIs market is experiencing steady growth due to the increasing prevalence of anxiety disorders, insomnia, seizures, and other neurological conditions worldwide. The market was valued at US$ 472.8 Mn in 2022 and is projected to surpass US$ 652.8 Mn by 2031, expanding at a CAGR of 3.6% from 2023 to 2031.
Growing awareness of mental health issues, rising healthcare...
0 Condivisioni
92 Visualizzazioni